Premium
Feasibility and benefit of hydroxycarbamide as a long‐term treatment for sickle cell disease patients: Results from the North West London Sickle Cell Disease Registry
Author(s) -
Gilmore Annette,
Cho Gavin,
Howard Jo,
Layton Mark,
Afif Michele,
Hughes Robert George,
Philpott Nicola J,
Patankar Sameer,
Davies Sally C.
Publication year - 2011
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.22146
Subject(s) - hydroxycarbamide , disease , medicine , cell , term (time) , pediatrics , intensive care medicine , genetics , biology , physics , quantum mechanics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom